Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectors

Virology

Volumn 345, Issue 1, 2006, Pages 220-230

  Howe, John A ^a   Pelka, Peter ^a   Antelman, Doug ^a   Wilson, Chris ^a   Cornell, Doug ^a   Hancock, Wendy ^a   Ramachandra, Murali ^a   Avanzini, Jenny ^a   Horn, Mark ^a   Wills, Ken ^a   Sutjipto, Suganto ^a   Ralston, Robert ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adenovirus; E1A; E1B; Gene Therapy; Production cells

Indexed keywords

ADENOVIRUS VECTOR; E1A PROTEIN; E1B PROTEIN; TRANSCRIPTION FACTOR; VIRUS DNA;

ARTICLE; CELL TRANSFORMATION; CLONING; FLOW CYTOMETRY; GENE CONSTRUCT; GENE THERAPY; GENETIC COMPLEMENTATION; HELA CELL; IMMUNOPRECIPITATION; LUNG TUMOR; NONHUMAN; PLASMID; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS GENE; VIRUS REPLICATION; WESTERN BLOTTING;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ADENOVIRUS E1B PROTEINS; BLOTTING, WESTERN; CELL LINE; DNA, VIRAL; GENES, REPORTER; GENETIC COMPLEMENTATION TEST; GENETIC VECTORS; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MUTAGENESIS, INSERTIONAL; RECOMBINATION, GENETIC; TRANSFECTION; VIRAL PROTEINS; VIRUS REPLICATION;

ADENOVIRIDAE; DNA VIRUSES;

EID: 30844442419     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.09.029     Document Type: Article

References (51)

1. L.E. Babiss, H.S. Ginsberg, and J.E. Darnell Jr. Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport Mol. Cell. Biol. 5 1985 2552 2558
2. C. Balague, F. Noya, R. Alemany, L.T. Chow, and D.T. Curiel Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes J. Virol. 75 2001 7602 7611
3. D.D. Barker, and A.J. Berk Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection Virology 156 1987 107 121
4. S.T. Bayley, and J.S. Mymryk Adenovirus E1A proteins and transformation (Review) Int. J. Oncol. 5 1994 425 444
5. P.E. Branton, S.T. Bayley, and F.L. Graham Transformation by human adenoviruses Biochim. Biophys. Acta 780 1985 67 94
6. C. Chartier, E. Degryse, M. Gantzer, A. Dieterle, A. Pavirani, and M. Mehtali Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli J. Virol. 70 1996 4805 4810
7. I.W. Cheney, D.E. Johnson, M.T. Vaillancourt, J. Avanzini, A. Morimoto, G.W. Demers, K.N. Wills, P.W. Shabram, J.B. Bolen, S.V. Tavtigian, and R. Bookstein Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer Cancer Res. 58 1998 2331 2334
8. M. Dobbelstein Replicating adenoviruses in cancer therapy Curr. Top. Microbiol. Immunol. 273 2004 291 334
9. K. Doronin, K. Toth, M. Kuppuswamy, P. Ward, A.E. Tollefson, and W.S. Wold Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein J. Virol. 74 2000 6147 6155
10. F.J. Fallaux, A. Bout, I. van der Velde, D.J. van den Wollenberg, K.M. Hehir, J. Keegan, C. Auger, S.J. Cramer, H. van Ormondt, A.J. van der Eb, D. Valerio, and R.C. Hoeben New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses Hum. Gene Ther. 9 1998 1909 1917
11. S.M. Frisch Antioncogenic effect of adenovirus E1A in human tumor cells Proc. Natl. Acad. Sci. U.S.A. 88 1991 9077 9081
12. S.M. Frisch, and J.S. Mymryk Adenovirus-5 E1A: paradox and paradigm antioncogenic effect of adenovirus E1A in human tumor cells Nat. Rev., Mol. Cell Biol. 3 2002 441 452
13. F.L. Graham, J. Smiley, W.C. Russell, and R. Nairn Characteristics of a human cell line transformed by DNA from human adenovirus type 5 J. Gen. Virol. 36 1977 59 74
14. J.N. Harada, and A.J. Berk p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication J. Virol. 73 1999 5333 5344
15. E. Harlow, B.R. Franza Jr., and C. Schley Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products J. Virol. 55 1985 533 546
16. B. Hirt Selective extraction of polyoma DNA from infected mouse cell cultures J. Mol. Biol. 26 1967 365 369
17. J.A. Howe, and S.T. Bayley Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A Virology 186 1992 15 24
18. J.A. Howe, J.S. Mymryk, C. Egan, P.E. Branton, and S.T. Bayley Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis Proc. Natl. Acad. Sci. U.S.A. 87 1990 5883 5887
19. J.A. Howe, G.W. Demers, D.E. Johnson, S.E. Neugebauer, S.T. Perry, M.T. Vaillancourt, and B. Faha Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapy Mol. Ther. 2 2000 485 495
20. A.V. Hubberstey, M. Pavliv, and R.J. Parks Cancer therapy utilizing an adenoviral vector expressing only E1A Cancer Gene Ther. 9 2002 321 329
21. B.G. Huyghe, X. Liu, S. Sutjipto, B.J. Sugarman, M.T. Horn, H.M. Shepard, C.J. Scandella, and P. Shabram Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography Hum. Gene Ther. 6 1995 1403 1416
22. J.L. Imler, C. Chartier, D. Dreyer, A. Dieterle, M. Sainte-Marie, T. Faure, A. Pavirani, and M. Mehtali Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors Gene Ther. 3 1996 75 84
23. N. Jones, and T. Shenk An adenovirus type 5 early gene function regulates expression of other early viral genes Proc. Natl. Acad. Sci. U.S.A. 76 1979 3665 3669
24. W.P. Lee, D.I. Tai, S.L. Tsai, C.T. Yeh, Y. Chao, S.D. Lee, and M.C. Hung Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine Cancer Res. 63 2003 6229 6236
25. H. Lochmuller, A. Jani, J. Huard, S. Prescott, M. Simoneau, B. Massie, G. Karpati, and G. Acsadi Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells Hum. Gene Ther. 5 1994 1485 1491
26. N. Louis, C. Evelegh, and F.L. Graham Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line Virology 233 1997 423 429
27. W. Lu, J. Lin, and J. Chen Expression of p14ARF overcomes tumor resistance to p53 Cancer Res. 62 2002 1305 1310
28. R.C. Marcellus, J.G. Teodoro, T. Wu, D.E. Brough, G. Ketner, G.C. Shore, and P.E. Branton Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis J. Virol. 70 1996 6207 6215
29. R.D. McKinnon, S. Bacchetti, and F.L. Graham Tn5 mutagenesis of the transforming genes of human adenovirus type 5 Gene 19 1982 33 42
30. O. Meier, and U.F. Greber Adenovirus endocytosis J. Gene Med. 5 2003 451 462
31. P. Murakami, E. Pungor, J. Files, L. Do, R. van Rijnsoever, R. Vogels, A. Bout, and M. McCaman A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles Hum. Gene Ther. 13 2002 909 920
32. J.S. Mymryk, K. Shire, and S.T. Bayley Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block Oncogene 9 1994 1187 1193
33. Z. Nahle, J. Polakoff, R.V. Davuluri, M.E. McCurrach, M.D. Jacobson, M. Narita, M.Q. Zhang, Y. Lazebnik, D. Bar-Sagi, and S.W. Lowe Direct coupling of the cell cycle and cell death machinery by E2F Nat. Cell Biol. 4 2002 859 864
34. T. Oh, C. Kim, S. Woo, T. Kim, D. Jeong, M. Kim, S. Lee, H. Cho, and S. An Development and clinical evaluation of a highly sensitive DNA microarray for detection and genotyping of human papillomaviruses J. Clin. Microbiol. 427 2004 3272 3280
35. G. Palu, C. Parolin, Y. Takeuchi, and M. Pizzato Progress with retroviral gene vectors Rev. Med. Virol. 10 2000 185 202
36. E. Querido, R.C. Marcellus, A. Lai, R. Charbonneau, J.G. Teodoro, G. Ketner, and P.E. Branton Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells J. Virol. 71 1997 3788 3798
37. M. Ramachandra, A. Rahman, A. Zou, M. Vaillancourt, J.A. Howe, D. Antelman, B. Sugarman, G.W. Demers, H. Engler, D. Johnson, and P. Shabram Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy Nat. Biotechnol. 19 2001 1035 1041
38. L. Rao, M. Debbas, P. Sabbatini, D. Hockenbery, S. Korsmeyer, and E. White The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins Proc. Natl. Acad. Sci. U.S.A. 89 1992 7742 7746
39. P. Sarnow, Y.S. Ho, J. Williams, and A.J. Levine Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells Cell 28 1982 387 394
40. P.W. Shabram, D.D. Giroux, A.M. Goudreau, R.J. Gregory, M.T. Horn, B.G. Huyghe, X. Liu, M.H. Nunnally, B.J. Sugarman, and S. Sutjipto Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles Hum. Gene Ther. 8 1997 453 465
41. T. Shenk Adenoviridae: the viruses and their replication K.D.M. B.N. Fields P.M. Howley Fields Virology vol. 2 1996 Lippincott-Raven Philadelphia, PA
42. J. Shisler, P. Duerksen-Hughes, T.M. Hermiston, W.S. Wold, and L.R. Gooding Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis J. Virol. 70 1996 68 77
43. C.D. Smith, D.W. Craft, R.S. Shiromoto, and P.O. Yan Alternative cell line for virus isolation J. Clin. Microbiol. 24 1986 265 268
44. J.G. Teodoro, G.C. Shore, and P.E. Branton Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms Oncogene 11 1995 467 474
45. N.T. Ueno, C. Bartholomeusz, J.L. Herrmann, Z. Estrov, R. Shao, M. Andreeff, J. Price, R.W. Paul, P. Anklesaria, D. Yu, and M.C. Hung E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway Clin. Cancer Res. 6 2000 250 259
46. E. White, R. Cipriani, P. Sabbatini, and A. Denton Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins J. Virol. 65 1991 2968 2978
47. P. Whyte, N.M. Williamson, and E. Harlow Cellular targets for transformation by the adenovirus E1A proteins Cell 56 1989 67 75
48. K.N. Wills, D.C. Maneval, P. Menzel, M.P. Harris, S. Sutjipto, M.T. Vaillancourt, W.M. Huang, D.E. Johnson, S.C. Anderson, and S.F. Wen Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer Hum. Gene Ther. 5 1994 1079 1088
49. G. Winberg, and T. Shenk Dissection of overlapping functions within the adenovirus type 5 E1A gene EMBO J. 3 1984 1907 1912
50. Z. Zhou, S.F. Jia, M.C. Hung, and E.S. Kleinerman E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs Cancer Res. 61 2001 3394 3398
51. J. Zhu, M. Grace, J. Casale, A.T. Chang, M.L. Musco, R. Bordens, R. Greenberg, E. Schaefer, and S.R. Indelicato Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector Hum. Gene Ther. 10 1999 113 121